SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-019834
Filing Date
2007-03-16
Accepted
2007-03-16 12:13:58
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-5567_110k.htm 10-K 1632506
2 EX-23.1 a07-5567_1ex23d1.htm EX-23.1 2855
3 EX-31.1 a07-5567_1ex31d1.htm EX-31.1 9653
4 EX-31.2 a07-5567_1ex31d2.htm EX-31.2 9577
5 EX-32.1 a07-5567_1ex32d1.htm EX-32.1 4088
6 EX-32.2 a07-5567_1ex32d2.htm EX-32.2 3935
7 GRAPHIC g55671dgi001.gif GRAPHIC 17032
  Complete submission text file 0001104659-07-019834.txt   1687781
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 07698801
SIC: 2835 In Vitro & In Vivo Diagnostic Substances